Senores Pharma IPO opens for subscription; should you bet on this pharma name?
Senores Pharmaceuticals is offering shares in the price band of Rs 372-391 apiece which can be applied for a minimum of 38 shares and its multiples to raise Rs 582.11 crore.
- Dec 20, 2024,
- Updated Dec 20, 2024 11:05 AM IST
The Rs 582.11 crore-initial public offering (IPO) of Senores Pharmaceuticals opens for bidding today, that is on, Friday, December 20, which will close for subscription on Tuesday, December 24. The pharma company shall be offering its shares in the range of Rs 372-391. Investors can apply for a minimum 38 equity shares and its multiples thereafter.
The company plans to use Rs 500 crore for debt repayment & funding capex & WC requirements in its subsidiaries in the form of debt, said Aditya Birla Money. "Although fairly priced, we see robust growth in the business with scope of improvement in profitability, hence we recommend 'subscribe' to the IPO," it added.
The Rs 582.11 crore-initial public offering (IPO) of Senores Pharmaceuticals opens for bidding today, that is on, Friday, December 20, which will close for subscription on Tuesday, December 24. The pharma company shall be offering its shares in the range of Rs 372-391. Investors can apply for a minimum 38 equity shares and its multiples thereafter.
The company plans to use Rs 500 crore for debt repayment & funding capex & WC requirements in its subsidiaries in the form of debt, said Aditya Birla Money. "Although fairly priced, we see robust growth in the business with scope of improvement in profitability, hence we recommend 'subscribe' to the IPO," it added.